台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    84.2
  • 漲跌
    ▼0.2
  • 漲幅
    -0.24%
  • 成交量
    313
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-統一-汐止 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-汐止 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/2700.00285.2085.40-2214-0.93%
2025/02/07180.0000.0080.0012050.49%
2025/01/22377.4000.0077.5031981.51%
2025/01/09177.0000.0076.8011920.52%
2025/01/06177.5000.0077.7011910.52%
2024/12/27477.5000.0077.7041852.16%
2024/10/1700.00977.8178.70-9144-6.22%
2024/10/1500.00179.6079.40-1150-0.66%
2024/10/0100.001082.1882.70-10173-5.75%
2024/09/1100.001778.9979.20-17254-6.68%
2024/09/0600.00679.4079.80-6263-2.28%
2024/08/2700.00179.5080.00-1287-0.35%
2024/08/1900.00380.5080.00-3294-1.02%
2024/08/16177.9000.0079.0012950.34%
2024/08/141078.1000.0078.40102953.39%
2024/08/09376.5000.0077.5032991.00%
2024/08/05271.601572.1072.50-13299-4.33%
2024/08/021079.4500.0079.50102913.43%
2024/08/01579.7000.0080.4052901.72%
2024/07/22181.402081.0881.60-19287-6.61%
2024/07/181283.1000.0083.20122804.27%
2024/07/1700.00684.4583.80-6279-2.15%
2024/07/16682.8500.0083.2062772.16%
2024/07/0100.00784.5084.50-7272-2.57%
2024/06/252385.7700.0083.50232608.83%
2024/06/21597.4000.0097.4052242.22%
2024/06/1900.00399.1098.00-3224-1.34%
2024/06/1800.0020.799.2898.50-20.7221-9.34%
2024/06/1700.000.299.0098.70-0.2220-0.08%
2024/06/14995.86696.7797.1032171.38%
2024/06/12796.4700.0097.5072233.13%
2024/06/111197.550.297.5097.4010.82234.84%
2024/06/0700.0019.4100.0499.60-19.4220-8.82%
2024/06/0600.001296.0395.80-12207-5.77%
2024/06/0400.00497.4095.80-4217-1.84%
2024/06/03294.5000.0094.7022230.90%
2024/05/31294.8000.0094.9022250.89%
2024/05/200.294.7000.0094.700.22700.06%
2024/05/160.494.2700.0094.000.43170.14%
2024/05/080.694.1400.0094.400.63200.17%
2024/05/06893.9000.0094.6083182.51%
2024/04/260.195.2000.0095.000.13180.03%
2024/04/24894.4000.0095.1083212.49%
2024/04/1600.00196.5096.80-1334-0.30%
2024/04/08099.9000.0099.6003290.00%
2024/04/0200.00199.5098.00-1330-0.30%
2024/04/0100.00698.3298.00-6333-1.80%
2024/03/2800.00498.1097.80-4343-1.17%
2024/03/27297.9000.0098.0023630.55%
2024/03/210.295.0000.0095.000.23780.05%
2024/03/15195.0000.0094.5013730.27%
2024/03/131094.69995.1495.7013700.27%
逸達兒童中樞性早熟三期臨床 三度獲DSMB正面回饋持續進行Anue鉅亨-22天前
逸達受美國經銷商指示不定期出貨 1月營收年減逾6成Anue鉅亨-2025/02/08
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-2025/01/14
逸達 相關文章
逸達 相關影音